Viemed Healthcare (VMD) Capital Leases (2023 - 2024)
Viemed Healthcare posted quarterly Capital Leases of $28000.0 for Q2 2024, down 80.42% year-on-year from $143000.0 in Q3 2023, and down 70.53% on a QoQ basis from $95000.0 in Q1 2024.
Viemed Healthcare (VMD) has 2 years of Capital Leases data on file, last reported at $28000.0 in Q2 2024.
- For the quarter ending Q2 2024, Capital Leases fell 80.42% year-over-year to $28000.0; the trailing twelve-month figure through Jun 2024 stood at $28000.0 (down 80.42% YoY), and the FY2023 full-year result was $132000.0, changed N/A from the prior year.
- Capital Leases for Q2 2024 stood at $28000.0, down from $95000.0 in the prior quarter.
- Across five years, Capital Leases topped out at $180000.0 in Q3 2023 and bottomed at $28000.0 in Q2 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Viemed Healthcare | 373.53 Mn | 365.70 Mn | 42.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 28,000.00 |
| Mar 31, 2024 | 95,000.00 |
| Dec 31, 2023 | 132,000.00 |
| Sep 30, 2023 | 180,000.00 |
| Jun 30, 2023 | 143,000.00 |